← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
76	76 Pluri PLUR $11.7M	42	+4	+11%	$3.49M
77	77 Calidi Biotherapeutics CLDI $2.26M	41	+1	+3%	$206M
78	SIOX 78 DELISTED Sio Gene Therapies Inc. Common Stock SIOX	41	0	0%	$8.53M
79	79 Opus Genetics IRD $341M	38	-3	-7%	$4.62M
80	SGTX 80 DELISTED Sigilon Therapeutics, Inc. Common Stock SGTX	37	-11	-23%	$14.2M
81	81 INmune Bio INMB $44.4M	36	+2	+6%	$17.4M
82	82 Eterna Therapeutics ERNA $2.46M	34	-15	-31%	$7.9M
83	83 Mesoblast MESO $1.79B	33	-4	-11%	$7.06M
84	GRCL 84 DELISTED Gracell Biotechnologies Inc. American Depositary Shares GRCL	32	-2	-6%	$176M
85	85 PharmaCyte Biotech PMCB $3.74M	32	+7	+28%	$8.79M
86	GRML 86 Greenland Mines Ltd GRML $86.6M	31	+31	–	$85.1M
87	PTE 87 DELISTED PolarityTE, Inc. Common Stock PTE	31	-13	-30%	$803K
88	BLCM 88 DELISTED Bellicum Pharmaceuticals, Inc. BLCM	30	+1	+3%	$2.22M
89	89 Capricor Therapeutics CAPR $383M	29	0	0%	$8.87M
90	90 BioCardia BCDA $14M	26	+2	+8%	$3.1M
91	ACHL 91 DELISTED Achilles Therapeutics ACHL	25	0	0%	$68.4M
92	ONCS 92 DELISTED OncoSec Medical Incorporated ONCS	25	-3	-11%	$3.86M
93	93 DELISTED Scorpius Holdings, Inc. SCPX	25	-4	-14%	$6.81M
94	94 Imunon IMNN $5.84M	24	+1	+4%	$1.69M
95	RCOR 95 DELISTED Renovacor, Inc. RCOR	24	0	0%	$16M
96	96 TScan Therapeutics TCRX $14.3M	24	-1	-4%	$30.4M
97	97 Candel Therapeutics CADL $694M	23	0	0%	$20.6M
98	98 Enlivex Ltd ENLV $4.29M	22	-3	-12%	$2.89M
99	99 Estrella Immunopharma ESLA $13.8M	22	+1	+5%	$33.9M
100	100 Senti Biosciences Holdings SNTI $7.5M	22	-24	-52%	$44.4M